✦ LIBER ✦

A Phase I/II Trial of Trastuzumab and Gefitinib in Patients with Metastatic Breast Cancer That Overexpresses HER2/neu (ErbB-2)

✍ Scribed by Stacy L. Moulder; Carlos L. Arteaga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of a HER2/neu bispecific

✍ V. Pullarkat; Y. Deo; J. Link; L. Spears; V. Marty; R. Curnow; S. Groshen; C. Ge 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

A phase I/II prospective, single arm tri

✍ G. Somlo; C. L. Martel; S. K. Lau; P. Frankel; C. Ruel; L. Gu; A. Hurria; C. Chu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 229 KB

A Phase I/II Trial of Trastuzumab plus E

✍ Carolyn D. Britten; Richard S. Finn; Linda D. Bosserman; Steven G. Wong; Michael 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

A phase II study of trastuzumab and cape

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Phase II Trial of Gemcitabine/Carboplati

✍ David Loesch; Lina Asmar; Kristi McIntyre; Lisa Doane; Michael Monticelli; Devch 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB